SyMap Medical
About:
SyMap Medical is an innovative medical device company.
Website: https://www.symapmedical.com
Top Investors: HongShan, Puhua Capital, Primavera Capital Group, VMS Asset Management, SBCVC
Description:
SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.
Total Funding Amount:
$110M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2012-08-10
Founders:
Kewen Jin, Wang Jie
Number of Employees:
51-100
Last Funding Date:
2021-12-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai